Market capitalization | $782.91m |
Enterprise Value | $954.81m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 6.35 |
P/S ratio (TTM) P/S ratio | 5.20 |
P/B ratio (TTM) P/B ratio | 17.47 |
Revenue growth (TTM) Revenue growth | 6.75% |
Revenue (TTM) Revenue | $150.45m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
4 Analysts have issued a Avid Bioservices, Inc. forecast:
4 Analysts have issued a Avid Bioservices, Inc. forecast:
Oct '24 |
+/-
%
|
||
Revenue | 150 150 |
7%
7%
|
|
Gross Profit | 12 12 |
35%
35%
|
|
EBITDA | -7.54 -7.54 |
1,408%
1,408%
|
EBIT (Operating Income) EBIT | -20 -20 |
109%
109%
|
Net Profit | -152 -152 |
1,190%
1,190%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Avid Bioservices, Inc. engages in the commercial manufacturing which focuses on biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. The firm specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions, and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
Head office | United States |
CEO | Nicholas Green |
Employees | 371 |
Founded | 1981 |
Website | avidbio.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.